Recombinant nonpathogenic polio-rhinovirus chimeras (PVSRIPO) recognize the poliovirus receptor (PVR) CD155, which is widely expressed in tumor cells and major components of the tumor microenvironment (TME) in solid tumors. This evidence concerns the gene PVR and neoplasm.